HRMY
Harmony Biosciences Holdings
42.10$
+0.2%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 97.1% | 29.5% | 61.6% | 65.6% | 59.4% | 55.6% | 58.0% | 71.3% | |
| 93.5% | 22.9% | 53.5% | 54.1% | 36.2% | 38.4% | 45.3% | 59.2% | |
| 93.5% | 22.9% | 53.5% | 54.1% | 47.9% | 43.6% | 46.8% | 61.0% | |
| 0.0% | 4.0% | 5.2% | 8.0% | 8.1% | 9.1% | 8.3% | 7.6% | |
| 0.0% | 1.0% | 0.9% | 1.0% | 0.6% | 0.7% | 0.7% | 0.4% | |
| 1.8% | 1.2% | 0.2% | 0.2% | 0.1% | – | – | – | |
| – | 67.7% | 38.0% | 33.2% | 23.9% | 16.9% | 11.3% | 7.0% | |
| 8.7% | 110.9% | 77.2% | 57.0% | 40.2% | 42.4% | 34.0% | 31.6% | |
| 8.1% | 18.6% | 31.5% | 12.4% | 11.7% | 20.2% | 17.5% | 19.8% | |
| – | – | – | 0.8% | 0.3% | 1.8% | 1.8% | 6.8% | |
| 1.6% | 6.0% | 0.6% | 0.2% | 0.6% | 2.2% | 1.4% | 1.4% | |
| – | 91.8% | 45.5% | 43.8% | 28.1% | 22.0% | 16.3% | 11.3% | |
| 91.3% | -10.9% | 22.8% | 43.0% | 59.8% | 57.6% | 66.0% | 68.4% | |
| -271.8% | -396.3% | -114.3% | -104.6% | -40.4% | -17.7% | 0.2% | 12.7% | |
| 55.2% | 59.7% | 13.5% | 13.7% | 9.1% | 7.4% | 5.8% | 4.6% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.